ABH - July 2021 Monthly Informational Handouts

July 29, 2021

Provider Bulletins & MSA Updates

  • Provider Bulletin No 190- Post COVID Provider Survey –  As we begin to transition back to our pre-COVID servicing model we would like to get some feedback regarding servicing.    Post-COVID Provider Survey was sent
  • Provider Bulletin No 191- Removal of Prior Authorization for Hepatitis C Treatment – Effective 4.1.2021 – product MAVYRET (glecaprevir/pibrentasvir) will no longer require clinical prior authorization when prescribed in accordance with Food and Drug Administration (FDA) approved labeling. 
  • Provider Bulletin No 192 – Updated MDHHS Guidelines for Assessing and testing for Hepatitis C in Pregnant women and Children – Please refer to the attached PHC Fact Sheet from MDHHS regarding testing